Summary
The Children's Hospital of Philadelphia (CHOP) is a childcare specialty hospital that provides pediatric healthcare solutions. The hospital concentrates on improving pediatric healthcare, and promotes children’s health through its medical discoveries. It carries out research in the areas of cardiac, genetics, cancer, orthopedics, fetal surgery, neonatology, gastroenterology and urology at its Children's Hospital of Philadelphia Research Institute. CHOP provides specialty programs for rare disorders such as thoracic insufficiency syndrome, hyperinsulinism, Cornelia de lange syndrome, eosinophilic esophagitis and biliary atresia. The hospital also operates a pediatric healthcare network, which includes pediatrician offices, specialty care centers and surgical centers. CHOP is headquartered in Philadelphia, Pennsylvania, the US.
The Children's Hospital of Philadelphia - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
The Children's Hospital of Philadelphia, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
The Children's Hospital of Philadelphia, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
The Children's Hospital of Philadelphia, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
The Children's Hospital of Philadelphia, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
The Children's Hospital of Philadelphia, Medical Devices Deals, 2010 to YTD 2016 9
The Children's Hospital of Philadelphia, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
The Children's Hospital of Philadelphia, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Spark Therapeutics Raises USD73 Million in Series B Financing 12
Spark Therapeutics Raises US$50 Million In Venture Financing 14
Partnerships 15
Biobase Enters Into Licensing Agreement With University of Southern California And Children’s Hospital of Philadelphia 15
Wave Life Sciences Enters into Research Agreement with Children’s Hospital of Philadelphia 17
Emory University And Children's Hospital of Philadelphia Enter Into Co-Development Agreement With Harvard University 19
Children's Hospital of Philadelphia Partners BGI 20
Licensing Agreements 21
Medgenics Extends Agreement with Children's Hospital of Philadelphia 21
Omixon Enters into Licensing Agreement with Children's Hospital of Philadelphia 22
Spark Therapeutics Enters into Licensing Agreement with Children’s Hospital of Philadelphia 23
Kolltan Pharma Enters Into Licensing And Research Agreement With Children's Hospital of Philadelphia For Pediatric Neuroblastoma Therapies 25
Eqalix Enters Into Licensing Agreement With Drexel University, University of Pennsylvania And Children's Hospital of Philadelphia 26
Debt Offering 27
Children’s Hospital Of Philadelphia Completes Private Placement Of Fixed-Rate Bonds For US$270 Million 27
The Children's Hospital of Philadelphia - Key Competitors 28
Key Employees 29
Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32
List of Tables
The Children's Hospital of Philadelphia, Pharmaceuticals & Healthcare, Key Facts 1
The Children's Hospital of Philadelphia, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
The Children's Hospital of Philadelphia, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
The Children's Hospital of Philadelphia, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
The Children's Hospital of Philadelphia, Deals By Therapy Area, 2010 to YTD 2016 8
The Children's Hospital of Philadelphia, Medical Devices Deals, 2010 to YTD 2016 9
The Children's Hospital of Philadelphia, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Spark Therapeutics Raises USD73 Million in Series B Financing 12
Spark Therapeutics Raises US$50 Million In Venture Financing 14
Biobase Enters Into Licensing Agreement With University of Southern California And Children’s Hospital of Philadelphia 15
Wave Life Sciences Enters into Research Agreement with Children’s Hospital of Philadelphia 17
Emory University And Children's Hospital of Philadelphia Enter Into Co-Development Agreement With Harvard University 19
Children's Hospital of Philadelphia Partners BGI 20
Medgenics Extends Agreement with Children's Hospital of Philadelphia 21
Omixon Enters into Licensing Agreement with Children's Hospital of Philadelphia 22
Spark Therapeutics Enters into Licensing Agreement with Children’s Hospital of Philadelphia 23
Kolltan Pharma Enters Into Licensing And Research Agreement With Children's Hospital of Philadelphia For Pediatric Neuroblastoma Therapies 25
Eqalix Enters Into Licensing Agreement With Drexel University, University of Pennsylvania And Children's Hospital of Philadelphia 26
Children’s Hospital Of Philadelphia Completes Private Placement Of Fixed-Rate Bonds For US$270 Million 27
The Children's Hospital of Philadelphia, Key Competitors 28
The Children's Hospital of Philadelphia, Key Employees 29
The Children's Hospital of Philadelphia, Other Locations 30
List of Figures
The Children's Hospital of Philadelphia, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
The Children's Hospital of Philadelphia, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
The Children's Hospital of Philadelphia, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
The Children's Hospital of Philadelphia, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
The Children's Hospital of Philadelphia, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
The Children's Hospital of Philadelphia, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
The Children's Hospital of Philadelphia, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
The Children's Hospital of Philadelphia, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
The Children's Hospital of Philadelphia, Medical Devices Deals, 2010 to YTD 2016 9
